Population Pharmacokinetic Modeling With Enterohepatic Circulation for AZD3241 in Healthy Subjects and Patients With Multiple System Atrophy

Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis

(2016) Hongmei Xu et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Population pharmacokinetics of naloxegol in a population of 1247 healthy subjects and patients

(2015) Nidal Al-Huniti et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Development of rapid multistep carbon-11 radiosynthesis of the myeloperoxidase inhibitor AZD3241 to assess brain exposure by PET microdosing

(2015) Peter Johnström et al.   NUCLEAR MEDICINE AND BIOLOGY

Intracellular neutrophil myeloperoxidase level in pediatric patients: significant age and gender variability

(2014) S. Nikulshin et al.   International Journal of Laboratory Hematology

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies

(2014) Florian Krismer et al.   PARKINSONISM & RELATED DISORDERS

Population pharmacokinetic analysis of sorafenib in patients with solid tumours

(2011) Lokesh Jain et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Development of population PK model with enterohepatic circulation for mycophenolic acid in patients with childhood-onset systemic lupus erythematosus

(2011) Catherine M. T. Sherwin et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Targeted overexpression of human α-synuclein in oligodendroglia induces lesions linked to MSA -like progressive autonomic failure

(2010) Sylvia Stemberger et al.   EXPERIMENTAL NEUROLOGY